ECJ (Liability for Defective Products – Pharmaceutical Laboratories : Judgment) Reference for a preliminary ruling – Directive 85/374/EEC – Liability for defective products – Article 4 – Pharmaceutical laboratories – Vaccination against hepatitis B – Multiple sclerosis – Proof of defect of vaccine and of causal link between the defect and the damage suffered – Burden of proof – Methods of proof – Lack of scientific consensus – Serious, specific and consistent evidence left to the discretion of the court ruling on the merits – Whether permissible – Conditions
Citations:
C-621/15, [2017] EUECJ C-621/15
Links:
Statutes:
Jurisdiction:
European
Consumer
Updated: 27 March 2022; Ref: scu.588310